Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigation of FOXM1 as a Potential New Target for Melanoma.
Miyashita A, Fukushima S, Nakahara S, Yamashita J, Tokuzumi A, Aoi J, Ichihara A, Kanemaru H, Jinnin M, Ihn H. Miyashita A, et al. Among authors: tokuzumi a. PLoS One. 2015 Dec 7;10(12):e0144241. doi: 10.1371/journal.pone.0144241. eCollection 2015. PLoS One. 2015. PMID: 26640950 Free PMC article.
AT-rich Interaction Domain-containing Protein 3B is a New Tumour Marker for Melanoma.
Nakahara S, Fukushima S, Yamashita J, Kubo Y, Tokuzumi A, Miyashita A, Harada M, Nakamura K, Jinnin M, Ihn H. Nakahara S, et al. Among authors: tokuzumi a. Acta Derm Venereol. 2017 Jan 4;97(1):112-114. doi: 10.2340/00015555-2449. Acta Derm Venereol. 2017. PMID: 27140933 Free article. No abstract available.
Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma.
Kubo Y, Fukushima S, Inamori Y, Tsuruta M, Egashira S, Yamada-Kanazawa S, Nakahara S, Tokuzumi A, Miyashita A, Aoi J, Kajihara I, Tomita Y, Wakamatsu K, Jinnin M, Ihn H. Kubo Y, et al. Among authors: tokuzumi a. J Dermatol Sci. 2019 Jan;93(1):33-40. doi: 10.1016/j.jdermsci.2018.10.001. Epub 2018 Oct 6. J Dermatol Sci. 2019. PMID: 30318169
MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma.
Nakahara S, Fukushima S, Okada E, Morinaga J, Kubo Y, Tokuzumi A, Matsumoto S, Tsuruta-Kadohisa M, Kimura T, Kuriyama H, Miyashita A, Kajihara I, Jinnin M, Ihn H. Nakahara S, et al. Among authors: tokuzumi a. J Dermatol Sci. 2020 Jan;97(1):77-79. doi: 10.1016/j.jdermsci.2019.11.010. Epub 2019 Nov 30. J Dermatol Sci. 2020. PMID: 31843231 No abstract available.
Induced pluripotent stem cell-derived myeloid cells expressing OX40 ligand amplify antigen-specific T cells in advanced melanoma.
Kimura T, Fukushima S, Okada E, Kuriyama H, Kanemaru H, Kadohisa-Tsuruta M, Kubo Y, Nakahara S, Tokuzumi A, Kajihara I, Makino K, Miyashita A, Aoi J, Makino T, Tsukamoto H, Nishimura Y, Inozume T, Zhang R, Uemura Y, Senju S, Ihn H. Kimura T, et al. Among authors: tokuzumi a. Pigment Cell Melanoma Res. 2020 Sep;33(5):744-755. doi: 10.1111/pcmr.12887. Epub 2020 May 18. Pigment Cell Melanoma Res. 2020. PMID: 32353897
Immunotherapy with 4-1BBL-Expressing iPS Cell-Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma.
Kuriyama H, Fukushima S, Kimura T, Kanemaru H, Miyashita A, Okada E, Kubo Y, Nakahara S, Tokuzumi A, Nishimura Y, Kajihara I, Makino K, Aoi J, Masuguchi S, Tsukamoto H, Inozume T, Zhang R, Nakatsura T, Uemura Y, Senju S, Ihn H. Kuriyama H, et al. Among authors: tokuzumi a. Int J Mol Sci. 2021 Feb 16;22(4):1958. doi: 10.3390/ijms22041958. Int J Mol Sci. 2021. PMID: 33669419 Free PMC article.